Charles Verwaest

13.4k total citations · 2 hit papers
21 papers, 8.8k citations indexed

About

Charles Verwaest is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Charles Verwaest has authored 21 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Charles Verwaest's work include Pituitary Gland Disorders and Treatments (5 papers), Nosocomial Infections in ICU (3 papers) and Surgical site infection prevention (3 papers). Charles Verwaest is often cited by papers focused on Pituitary Gland Disorders and Treatments (5 papers), Nosocomial Infections in ICU (3 papers) and Surgical site infection prevention (3 papers). Charles Verwaest collaborates with scholars based in Belgium, Netherlands and United States. Charles Verwaest's co-authors include Peter Lauwers, Miet Schetz, Greet Van den Berghe, Patrick Ferdinande, Pieter Wouters, Roger Bouillon, Dirk Vlasselaers, Frank Weekers, Frans Bruyninckx and Francis de Zegher and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Critical Care Medicine.

In The Last Decade

Charles Verwaest

21 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intensive Insulin Therapy in Critically Ill Patients

2001 6.5k citations Greet Van den Berghe, Pieter Wouters et al. New England Journal of Medicine profile →
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*

2003 968 citations Greet Van den Berghe, Pieter Wouters et al. Critical Care Medicine profile →

Peers

Countries citing papers authored by Charles Verwaest

Since Specialization

Citations

This map shows the geographic impact of Charles Verwaest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Verwaest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Verwaest more than expected).

Fields of papers citing papers by Charles Verwaest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Verwaest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Verwaest. The network helps show where Charles Verwaest may publish in the future.

Co-authorship network of co-authors of Charles Verwaest

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Verwaest. A scholar is included among the top collaborators of Charles Verwaest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Verwaest. Charles Verwaest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liver fatty acid-binding protein: An early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors 2005 ·Transplantation Proceedings ·Diethard Monbaliu, Bart de Vries, (unknown), Ernest van Heurn, Charles Verwaest, Tania Roskams, Johan Fevery, Jacques Pirenne, Wim A. Buurman	32
2	Effect of mechanical bowel preparation with polyethyleneglycol on bacterial contamination and wound infection in patients undergoing elective open colon surgery 2005 ·Clinical Microbiology and Infection ·Patrick Fa-Si-Oen, Charles Verwaest, (unknown), Hein Putter, J.W.D. de Waard, Cornelis J.�H. van de Velde, Rudi M. H. Roumen	29
3	Bacteriology of abdominal wounds in elective open colon surgery: a prospective study of 100 surgical wounds 2005 ·Clinical Microbiology and Infection ·Patrick Fa-Si-Oen, (unknown), (unknown), Charles Verwaest, Rudi M. H. Roumen	18
4	Mechanical Bowel Preparation or Not? Outcome of a Multicenter, Randomized Trial in Elective Open Colon Surgery 2005 ·Diseases of the Colon & Rectum ·Patrick Fa-Si-Oen, Rudi M. H. Roumen, (unknown), Cornelis J.�H. van de Velde, Dick van Geldere, Hein Putter, Charles Verwaest, (unknown), (unknown), Dingeman J. Swank, André D’Hoore, (unknown)	137
5	Livers from Non???Heart-Beating Donors Tolerate Short Periods of Warm Ischemia 2005 ·Transplantation ·Diethard Monbaliu, (unknown), Tania Roskams, Johan Fevery, Charles Verwaest, Jacques Pirenne	71
6	Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial 2004 ·Intensive Care Medicine ·Bart Rijnders, Willy Peetermans, Charles Verwaest, Alexander Wilmer, Eric Van Wijngaerden	81
7	Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* breakdown → 2003 ·Critical Care Medicine ·Greet Van den Berghe, Pieter Wouters, Roger Bouillon, Frank Weekers, Charles Verwaest, Miet Schetz, Dirk Vlasselaers, Patrick Ferdinande, Peter Lauwers	968
8	Factors Affecting Mortality in Generalized Postoperative Peritonitis: Multivariate Analysis in 96 Patients 2003 ·World Journal of Surgery ·Stefaan Mulier, Freddy Penninckx, Charles Verwaest, Ludo Filez, Raymond Aerts, Steffen Fieuws, Peter Lauwers	130
9	Intensive Insulin Therapy in Critically Ill Patients breakdown → 2001 ·New England Journal of Medicine ·Greet Van den Berghe, Pieter Wouters, Frank Weekers, Charles Verwaest, Frans Bruyninckx, Miet Schetz, Dirk Vlasselaers, Patrick Ferdinande, Peter Lauwers, Roger Bouillon	6523
10	Difference in time to positivity of hub-blood versus nonhub-blood cultures is not useful for the diagnosis of catheter-related bloodstream infection in critically ill patients 2001 ·Critical Care Medicine ·Bart Rijnders, Charles Verwaest, Willy Peetermans, Alexander Wilmer, Stefaan J. Vandecasteele, Johan Van Eldere, Eric Van Wijngaerden	54
11	Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit 2000 ·Clinical Microbiology and Infection ·Charles Verwaest	50
12	Neuroendocrinology of Prolonged Critical Illness: Effects of Exogenous Thyrotropin-Releasing Hormone and Its Combination with Growth Hormone Secretagogues¹ 1998 ·The Journal of Clinical Endocrinology & Metabolism ·Greet Van den Berghe, Francis de Zegher, Robert C. Baxter, Johannes D. Veldhuis, Pieter Wouters, Miet Schetz, Charles Verwaest, (unknown), Peter Lauwers, Roger Bouillon, Cyril Y. Bowers	160
13	The Somatotropic Axis in Critical Illness: Effect of Continuous Growth Hormone (GH)-Releasing Hormone and GH-Releasing Peptide-2 Infusion¹ 1997 ·The Journal of Clinical Endocrinology & Metabolism ·Greet Van den Berghe, Francis de Zegher, Paula P. Veldhuis, Pieter Wouters, (unknown), (unknown), Miet Schetz, Charles Verwaest, Peter Lauwers, Roger Bouillon, Cyril Y. Bowers	112
14	Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit 1997 ·Critical Care Medicine ·Charles Verwaest, Jan Verhaegen, Patrick Ferdinande, Miet Schetz, Greet Van den Berghe, L. Verbist, Peter Lauwers	136
15	Meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in ICU: an open randomised multicentre study 1997 ·Critical Care ·Charles Verwaest	1
16	Thyrotropin-releasing hormone in critical illness 1996 ·Critical Care Medicine ·(unknown), Francis de Zegher, Dirk Vlasselaers, Miet Schetz, Charles Verwaest, (unknown), Peter Lauwers	31
17	Pituitary responsiveness to GH‐releasing hormone, GH‐releasing peptide‐2 and thyrotrophin‐releasing hormone in critical illness 1996 ·Clinical Endocrinology ·Greet Van den Berghe, Francis de Zegher, Cyril Y. Bowers, Pieter Wouters, P Müller, (unknown), Dirk Vlasselaers, Miet Schetz, Charles Verwaest, Peter Lauwers, Roger Bouillon	58
18	Pharmacokinetics of continuous renal replacement therapy 1995 ·Intensive Care Medicine ·Miet Schetz, Patrick Ferdinande, Greet Van den Berghe, Charles Verwaest, Peter Lauwers	83
19	Removal of pro-inflammatory cytokines with renal replacement therapy: Sense or nonsense? 1995 ·Intensive Care Medicine ·Miet Schetz, Patrick Ferdinande, Greet Van den Berghe, Charles Verwaest, Peter Lauwers	74
20	Dehydroepiandrosterone sulphate in critical illness: effect of dopamine 1995 ·Clinical Endocrinology ·Greet Van den Berghe, Francis de Zegher, Pieter Wouters, Miet Schetz, Charles Verwaest, (unknown), Peter Lauwers	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact